查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1960040

獸醫腎臟疾病市場－全球產業規模、佔有率、趨勢、機會和預測：按類型、動物種類、給藥途徑、最終用途、地區和競爭格局分類，2021-2031年

Veterinary Renal Disease Market - Global Industry Size, Share, Trends, Opportunity and Forecast, Segmented By Type, By Animal type, By Route of Administration, By End Use, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 182 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球獸醫腎臟疾病市場預計將從 2025 年的 179.9 億美元成長到 2031 年的 243.7 億美元，複合年成長率為 5.19%。

該市場涵蓋用於檢測和治療家畜及伴侶動物腎功能障礙的治療藥物、診斷設備和特殊營養食品。主要成長要素包括老年寵物慢性腎臟病率的上升以及全球寵物數量的成長。這些因素增加了對持續獸醫護理的需求。與短暫的科技潮流不同，這些因素源自於人們對動物更深層的人文關懷，促使飼主投入大量資金來延長寵物的壽命並提高其生活品質。

市場概覽
預測期 2027-2031
市場規模：2025年 179.9億美元
市場規模：2031年 243.7億美元
複合年成長率：2026-2031年 5.19%
成長最快的細分市場 診斷
最大的市場 北美洲

然而，持續的獸醫護理費用仍然是一大障礙。經濟拮据往往導致治療延誤或放棄必要的長期腎臟治療，阻礙了產生收入。美國獸醫協會2024年的數據凸顯了這個問題，數據顯示，美國家庭在獸醫護理方面的平均支出比去年同期下降了4%。這一降幅表明，寵物飼主的經濟敏感性仍然是全面實施腎臟疾病綜合管理策略的主要障礙。

市場促進因素

慢性腎臟病(CKD) 在老年伴侶動物中的日益普遍，正成為市場成長的主要催化劑，推動獸醫通訊協定向早期檢測和監測方向的根本性轉變。隨著綜合護理水準的提高延長了犬貓的平均壽命，易受老齡化相關性腎功能衰退影響的動物數量自然增加，因此獸醫診所需要開展更積極主動、更規律的篩檢。這種人口結構的變化直接推動了用於識別症狀前腎損傷的診斷試劑盒和生物標記的引入。例如，IDEXX Laboratories 在 2024 年 10 月發布的 2024 年第三季財報中指出，其診斷業務的經常性收入實​​現了 7%的內部成長，這主要得益於預防性健康檢測的增加以及一系列腎臟疾病管理解決方案的研發。

同時，寵物人性化趨勢的日益增強以及醫療保健支出的增加，提升了營養支持和先進腎臟治療的商業性可行性。飼主越來越將寵物視為家庭成員，導致他們對高階醫療食品和維持生命藥物的價格敏感度降低。碩騰（Zoetis）的案例便印證了這一趨勢。該公司在2024年11月發布的2024年第三季財報中顯示，其伴侶動物產品組合的全球營收成長了15%，顯示該公司對動物保健領域的堅定投資。此外，雀巢在2024年7月發布的2024年上半年財報顯示，普瑞納寵物食品（Purina PetCare）的銷售額達到約107億美元，這主要得益於市場對科學配方獸用處方食品的需求。

市場挑戰

持續的獸醫護理高成本，直接阻礙了全球獸醫腎臟疾病市場的成長。腎臟疾病的治療會帶來持續的經濟負擔，包括反覆的診斷測試、終身服藥以及昂貴的治療性處方糧。這些累積的費用是繼續治療的主要障礙，對價格敏感的飼主往往選擇安寧療護或普通商業食品，而不是昂貴的處方糧。這種消費行為限制了腎臟專科產品的潛在市場，也阻礙了生產商和獸醫診所充分實現其治療產品組合的獲利。

近期數據顯示，經濟壓力影響飼主的決策，凸顯了這個經濟負擔。 2024年，PDSA報告稱，“26%的犬飼主表示生活開支影響了他們對寵物的照顧”，這表明許多飼主因費用問題而推遲帶寵物就醫。這項統計數據表明，經濟敏感性已成為一種普遍趨勢，導致寵物就醫頻率降低，腎臟疾病治療方案的使用量也減少。

市場趨勢

將人工智慧 (AI) 整合到腎臟診斷工具中，透過提高腎功能障礙識別的準確性和速度，正在改變獸醫腎臟病學。血液和尿液檢查平台中的 AI 驅動演算法可自動檢測腎臟健康的關鍵指標—病理成分，例如尿液結晶和輸尿管管型。與傳統方法相比，這項技術減少了人工判讀的差異，並能更早發現腎功能的變化。例如，在 2024 年 12 月題為「碩騰宣布 Vetscan Imagyst 功能增強」的新聞稿中，碩騰宣布了 AI 增強功能，包括可識別特定結晶的高級尿沉渣分析，從而支持數據驅動的即時臨床決策。

同時，無論是急性病例或慢性病例，對即時治療方案調整的需求正推動著腎功能照護現場檢測解決方案的顯著發展。獸醫擴大使用先進的院內分析儀即時評估關鍵腎臟生物標記物，從而最大限度地減少對外部實驗室的依賴，並實現當日診療。這種能力對於監測腎功能受損患者的水合狀態和藥物調整至關重要。根據IDEXX Laboratories於2025年2月發布的2024年第四季及全年財報，其院內VetLab耗材實現了12%的有機收入成長，凸顯了臨床上對快速診斷基礎設施的日益青睞，以應對腎臟疾病等複雜病症。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球獸醫腎臟疾病市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 按類型（診斷、治療）
    • 動物種類（狗、貓、馬、牛、其他）
    • 給藥途徑（口服、注射）
    • 透過申請（獸醫醫院/診所、寵物店、電子商務、其他）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美獸醫腎臟疾病市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲獸醫腎臟疾病市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區獸醫腎臟疾病市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲獸醫腎臟疾病市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲獸醫腎臟疾病市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球獸醫腎臟疾病市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Zoetis Inc
  • Nestle Purina PetCare
  • Mars Inc.
  • Hill's Pet Nutrition, Inc.
  • The JM Smucker Company
  • General Mills Inc.
  • Merck & Co., Inc
  • Elanco Animal Health Inc.
  • Phibro Animal Health Corporation
  • Ceva Sante Animale

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 23951

The Global Veterinary Renal Disease Market is projected to expand from USD 17.99 Billion in 2025 to USD 24.37 Billion by 2031, reflecting a compound annual growth rate of 5.19%. This market encompasses therapeutic pharmaceuticals, diagnostic instruments, and specialized dietary formulations aimed at detecting and managing kidney dysfunction in livestock and companion animals. Key growth drivers include the rising incidence of chronic kidney disease within aging pet populations and increased global pet adoption, which fuels the need for consistent veterinary care. Unlike fleeting technological fads, these drivers are rooted in the profound humanization of animals, motivating owners to invest substantially in prolonging their pets' lives and enhancing their quality of life.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 17.99 Billion
Market Size 2031USD 24.37 Billion
CAGR 2026-20315.19%
Fastest Growing SegmentDiagnosis
Largest MarketNorth America

However, the market encounters significant obstacles related to the affordability of continuous veterinary care. Financial limitations often result in deferred treatments or the refusal of essential long-term renal therapies, which hinders revenue generation. Data from the 'American Veterinary Medical Association' in '2024' highlights this issue, showing a 4% decrease in the average household expenditure on veterinary care compared to the prior year. This decline suggests that financial sensitivity among pet owners persists as a major barrier to the broad implementation of comprehensive renal disease management strategies.

Market Driver

The increasing prevalence of chronic kidney disease (CKD) among aging companion animals acts as a major catalyst for market growth, prompting a fundamental shift in veterinary protocols toward early detection and monitoring. As improved general care extends the life expectancies of dogs and cats, the population vulnerable to age-related renal degeneration naturally grows, necessitating more aggressive routine screening in veterinary clinics. This demographic evolution directly fuels the adoption of diagnostic panels and biomarkers required to identify kidney dysfunction prior to symptom onset. For instance, IDEXX Laboratories reported in their 'Third Quarter 2024 Financial Results' from October 2024 that diagnostics recurring revenue saw a 7% organic growth, driven by volume gains in preventative care testing, creating a pipeline for renal disease management solutions.

Concurrently, the rising trend of pet humanization and increased healthcare spending boosts the commercial viability of nutritional support and advanced renal therapies. Owners increasingly regard pets as family members, reducing price sensitivity toward premium medical diets and life-extending pharmaceutical treatments. This is evidenced by Zoetis, which reported in November 2024's 'Third Quarter 2024 Financial Results' that operational revenue for their companion animal portfolio rose by 15% globally, highlighting strong investment in animal health. Furthermore, Nestle's 'Half-Year Results 2024' from July 2024 indicated that Purina PetCare sales hit approximately $10.7 billion, driven significantly by the demand for science-based veterinary formulations.

Market Challenge

The high cost of ongoing veterinary care presents a direct obstacle to the growth of the Global Veterinary Renal Disease Market. Managing kidney disease requires a sustained financial commitment involving repeated diagnostic testing, lifelong medication, and premium therapeutic diets. These cumulative costs create significant adherence barriers; consequently, price-sensitive owners often choose palliative care or standard commercial foods over expensive prescription formulations. Such consumer behavior restricts the addressable market for specialized renal products, limiting the ability of manufacturers and clinics to fully capitalize on their therapeutic portfolios.

This financial strain is emphasized by recent data highlighting the economic pressures affecting owner decision-making. In '2024', the 'PDSA' reported that '26% of dog owners indicated that the cost of living affected their ability to care for their pets', with many delaying veterinary visits due to expense. This statistic underscores that economic sensitivity is a prevailing trend that diminishes the frequency of veterinary interventions and reduces the consumption of renal disease management solutions.

Market Trends

The integration of Artificial Intelligence into renal diagnostic tools is transforming veterinary nephrology by improving the accuracy and speed of identifying kidney dysfunction. AI-driven algorithms within hematology and urinalysis platforms now automate the detection of pathological elements, such as urinary crystals and casts, which are vital indicators of renal health. This technology reduces manual interpretation variability and allows for earlier detection of kidney function changes compared to traditional methods. For example, in a December 2024 press release titled 'Zoetis to Expand Vetscan Imagyst Capabilities', Zoetis announced AI-powered enhancements including advanced urine sediment analysis to identify specific crystals, facilitating immediate, data-driven clinical decisions.

Simultaneously, there is a marked shift toward point-of-care renal function testing solutions, driven by the need for immediate treatment adjustments in both acute and chronic cases. Veterinarians are increasingly utilizing advanced in-clinic analyzers that offer real-time assessments of key renal biomarkers, thereby minimizing reliance on reference laboratories and enabling same-day management. This capability is crucial for monitoring fluid and medication adjustments in renally compromised patients. According to IDEXX Laboratories' 'Fourth Quarter and Full Year 2024 Results' from February 2025, in-clinic VetLab consumables achieved 12% organic revenue growth, underscoring the rising clinical preference for rapid diagnostic infrastructure to manage complex conditions like renal disease.

Key Market Players

  • Zoetis Inc
  • Nestle Purina PetCare
  • Mars Inc.
  • Hill's Pet Nutrition, Inc.
  • The J.M. Smucker Company
  • General Mills Inc.
  • Merck & Co., Inc
  • Elanco Animal Health Inc.
  • Phibro Animal Health Corporation
  • Ceva Sante Animale

Report Scope

In this report, the Global Veterinary Renal Disease Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Veterinary Renal Disease Market, By Type

  • Diagnosis
  • Treatment

Veterinary Renal Disease Market, By Animal type

  • Canine
  • Feline
  • Equine
  • Bovine
  • Others

Veterinary Renal Disease Market, By Route of Administration

  • Oral
  • Injectable

Veterinary Renal Disease Market, By End Use

  • Veterinary Hospitals & Clinics
  • Pet Specialty Stores
  • E-commerce
  • Others

Veterinary Renal Disease Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Veterinary Renal Disease Market.

Available Customizations:

Global Veterinary Renal Disease Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Veterinary Renal Disease Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Diagnosis, Treatment)
    • 5.2.2. By Animal type (Canine, Feline, Equine, Bovine, Others)
    • 5.2.3. By Route of Administration (Oral, Injectable)
    • 5.2.4. By End Use (Veterinary Hospitals & Clinics, Pet Specialty Stores, E-commerce, Others)
    • 5.2.5. By Region
    • 5.2.6. By Company (2025)
  • 5.3. Market Map

6. North America Veterinary Renal Disease Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Animal type
    • 6.2.3. By Route of Administration
    • 6.2.4. By End Use
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Veterinary Renal Disease Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Animal type
        • 6.3.1.2.3. By Route of Administration
        • 6.3.1.2.4. By End Use
    • 6.3.2. Canada Veterinary Renal Disease Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Animal type
        • 6.3.2.2.3. By Route of Administration
        • 6.3.2.2.4. By End Use
    • 6.3.3. Mexico Veterinary Renal Disease Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Animal type
        • 6.3.3.2.3. By Route of Administration
        • 6.3.3.2.4. By End Use

7. Europe Veterinary Renal Disease Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Animal type
    • 7.2.3. By Route of Administration
    • 7.2.4. By End Use
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Veterinary Renal Disease Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Animal type
        • 7.3.1.2.3. By Route of Administration
        • 7.3.1.2.4. By End Use
    • 7.3.2. France Veterinary Renal Disease Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Animal type
        • 7.3.2.2.3. By Route of Administration
        • 7.3.2.2.4. By End Use
    • 7.3.3. United Kingdom Veterinary Renal Disease Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Animal type
        • 7.3.3.2.3. By Route of Administration
        • 7.3.3.2.4. By End Use
    • 7.3.4. Italy Veterinary Renal Disease Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Animal type
        • 7.3.4.2.3. By Route of Administration
        • 7.3.4.2.4. By End Use
    • 7.3.5. Spain Veterinary Renal Disease Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Animal type
        • 7.3.5.2.3. By Route of Administration
        • 7.3.5.2.4. By End Use

8. Asia Pacific Veterinary Renal Disease Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Animal type
    • 8.2.3. By Route of Administration
    • 8.2.4. By End Use
    • 8.2.5. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Veterinary Renal Disease Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Animal type
        • 8.3.1.2.3. By Route of Administration
        • 8.3.1.2.4. By End Use
    • 8.3.2. India Veterinary Renal Disease Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Animal type
        • 8.3.2.2.3. By Route of Administration
        • 8.3.2.2.4. By End Use
    • 8.3.3. Japan Veterinary Renal Disease Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Animal type
        • 8.3.3.2.3. By Route of Administration
        • 8.3.3.2.4. By End Use
    • 8.3.4. South Korea Veterinary Renal Disease Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Animal type
        • 8.3.4.2.3. By Route of Administration
        • 8.3.4.2.4. By End Use
    • 8.3.5. Australia Veterinary Renal Disease Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Animal type
        • 8.3.5.2.3. By Route of Administration
        • 8.3.5.2.4. By End Use

9. Middle East & Africa Veterinary Renal Disease Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Animal type
    • 9.2.3. By Route of Administration
    • 9.2.4. By End Use
    • 9.2.5. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Veterinary Renal Disease Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Animal type
        • 9.3.1.2.3. By Route of Administration
        • 9.3.1.2.4. By End Use
    • 9.3.2. UAE Veterinary Renal Disease Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Animal type
        • 9.3.2.2.3. By Route of Administration
        • 9.3.2.2.4. By End Use
    • 9.3.3. South Africa Veterinary Renal Disease Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Animal type
        • 9.3.3.2.3. By Route of Administration
        • 9.3.3.2.4. By End Use

10. South America Veterinary Renal Disease Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Animal type
    • 10.2.3. By Route of Administration
    • 10.2.4. By End Use
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Veterinary Renal Disease Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Animal type
        • 10.3.1.2.3. By Route of Administration
        • 10.3.1.2.4. By End Use
    • 10.3.2. Colombia Veterinary Renal Disease Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Animal type
        • 10.3.2.2.3. By Route of Administration
        • 10.3.2.2.4. By End Use
    • 10.3.3. Argentina Veterinary Renal Disease Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Animal type
        • 10.3.3.2.3. By Route of Administration
        • 10.3.3.2.4. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Veterinary Renal Disease Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Zoetis Inc
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Nestle Purina PetCare
  • 15.3. Mars Inc.
  • 15.4. Hill's Pet Nutrition, Inc.
  • 15.5. The J.M. Smucker Company
  • 15.6. General Mills Inc.
  • 15.7. Merck & Co., Inc
  • 15.8. Elanco Animal Health Inc.
  • 15.9. Phibro Animal Health Corporation
  • 15.10. Ceva Sante Animale

16. Strategic Recommendations

17. About Us & Disclaimer